跳到正文
Longevity.Technology (@LongevityTech)· LongevityTech·· 3 天前评分8

BioCardia完成日本监管咨询,瞄准2028年首批患者

BioCardia wraps up consultations with Japan’s regulator on CardiAMP and now aims for a marketing application, with first patients in 2028.

导读

BioCardia就CardiAMP完成与日本监管机构的咨询,现计划提交上市申请,首批患者预计于2028年入组。 https://vist.ly/5tgrq #longevity #biotech #cardiovascularhealth #celltherapy #clinicaltrials

来源:Longevity.Technology (@LongevityTech) · x.com